The RxPress
RxPress Issues
- Acetaminophen: recommendations from the FDA Advisory Committee
- Recombinant human erythropoiesis-stimulating agents and mortality in cancer patients
- Hospital-acquired pneumonia: risks with acid suppression therapies
- Updated guidelines for nutrition support in the adult critically ill patient: SCCM and A.S.P.E.N.
- P&T Committee Formulary Action
- Antiplatelet therapy and GI Risk
- Update on HIV Opportunistic Infections
- Aspirin for Primary Prevention
- Update on PPI and Clopidogrel Interaction
- P&T Committee Formulary Action
- Intensive Glycemic Control and Cardiovascular Events: An Update
- The Utilization of Pharmacogenomics in Clinical Practice
- Dalteparin Use Guideline
- P&T Committee Formulary Action
November-December 2008 edition
- Antiretrovirals in Adults and Adolescents
- Immunizations in Adults
- Influenza Immunizations in Children
- American College of Physician Statement on HIV Screening
- Clinical Care Guidelines: Piperacillin-tazobactam Extended Infusion in Adults
- P&T Committee Formulary Action
September-October 2008 edition
- Risk Evaluation and Mitigation Strategy (REMS)
- New ACCP Thrombosis Guidelines
- New Cancer Data with Vytorin
- P&T Committee Formulary Action
- Ambulatory blood pressure monitoring in children and adolescents: recommendations and standard assessments
- Clinical practice guidelines for cholesterol screening in children
- Clinical practice guidelines for febrile seizures
- P&T Formulary Update
- Short-term Safety of Antipsychotics for Dementia
- Preoperative Statins and Effects on Mortality
- Hormone Replacement Therapy and Risk of Venous Thromboembolism
- P&T Formulary Update
- Risk of myocardial infarction with antiretroviral use
- Drug induced suicidality
- Pediatric medication errors
- P&T Formulary Update
- Haloperidol and cardiovascular concerns
- Recent warnings regarding sedative-hypnotics
- EDTA medication errors
- Medical Center sales representative policy
- P&T Formulary Update
^ Top of Page ^